014570 Stock Chart & Stats
₩3500.00
₩0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range₩3,060.00 - ₩4,700.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)6.02K
Market Cap
₩37.87B
Enterprise Value-₩751.70
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)25.5
Beta0.04
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-317.82
Shares Outstanding11,000,000
10 Day Avg. Volume5,860
30 Day Avg. Volume6,023
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
014570 FAQ
What was Korean Drug Co., Ltd’s price range in the past 12 months?
Korean Drug Co., Ltd lowest stock price was ₩3060.00 and its highest was ₩4700.00 in the past 12 months.
What is Korean Drug Co., Ltd’s market cap?
Korean Drug Co., Ltd’s market cap is ₩37.87B.
When is Korean Drug Co., Ltd’s upcoming earnings report date?
Korean Drug Co., Ltd’s upcoming earnings report date is Nov 18, 2026 which is in 70 days.
How were Korean Drug Co., Ltd’s earnings last quarter?
Korean Drug Co., Ltd released its earnings results on Aug 19, 2026. The company reported -₩317.824 earnings per share for the quarter.
Is Korean Drug Co., Ltd overvalued?
According to Wall Street analysts Korean Drug Co., Ltd’s price is currently Undervalued.
Does Korean Drug Co., Ltd pay dividends?
Korean Drug Co., Ltd does not currently pay dividends.
What is Korean Drug Co., Ltd’s EPS estimate?
Korean Drug Co., Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Korean Drug Co., Ltd have?
Korean Drug Co., Ltd has 11,000,000 shares outstanding.
What happened to Korean Drug Co., Ltd’s price movement after its last earnings report?
Korean Drug Co., Ltd reported an EPS of -₩317.824 in its last earnings report. Following the earnings report the stock price went down -0.444%.
Which hedge fund is a major shareholder of Korean Drug Co., Ltd?
Currently, no hedge funds are holding shares in KR:014570
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
GREEN LIFESCIENCE CO. LTD.
―
SYNTEKABIO, INC.
―
Gencurix, Inc.
―
KOREA ARLICO PHARM CO.,LTD.
―
Oncocross Co., Ltd.
―